- Report
- March 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- April 2023
- 120 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- February 2024
- 160 Pages
Global
From €4724EUR$4,969USD£3,968GBP
- Report
- October 2023
- 140 Pages
Global
From €3421EUR$3,599USD£2,874GBP
- Report
- September 2023
- 160 Pages
Global
From €3421EUR$3,599USD£2,874GBP
- Report
- May 2023
- 147 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- April 2023
- 147 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- November 2023
- 300 Pages
Global
€4749EUR$4,995USD£3,989GBP
- Report
- January 2024
- 100 Pages
Africa
From €1901EUR$2,000USD£1,597GBP
- Report
- January 2024
- 300 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- January 2024
- 80 Pages
United States
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2024
- 80 Pages
United Kingdom
From €1426EUR$1,500USD£1,198GBP
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2024
- 80 Pages
South Korea
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2024
- 80 Pages
Saudi Arabia
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2024
- 80 Pages
India
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2024
- 80 Pages
Germany
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2024
- 80 Pages
France
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2024
- 80 Pages
China
From €1426EUR$1,500USD£1,198GBP
- Report
- August 2023
- 100 Pages
Africa
From €1901EUR$2,000USD£1,597GBP

In biotechnology, the nucleotide market encompasses the production and sale of nucleotides, which are the basic building blocks of nucleic acids, namely DNA and RNA. This market serves a diverse array of applications including research, pharmaceuticals, diagnostics, and agricultural biotechnology. The synthesis of custom nucleotides enables advancements in genetic engineering, gene sequencing, and personalized medicine. Companies in this sector often provide both individual nucleotides for research and therapeutic purposes as well as oligonucleotides, which are short sequences of nucleotides synthesized to match specific DNA or RNA sequences for use in experiments or as drugs. The demand in this market is driven by the expanding understanding of genetic material and the increasing applicability of nucleic acid-based technologies. Environmental concerns and regulations also influence the production and sale of nucleotides.
Key players in the nucleotide market include Thermo Fisher Scientific, a prominent provider of scientific instrumentation and reagents; Sigma-Aldrich (now part of Merck KGaA), known for chemicals and nucleotides for research purposes; Illumina, which specializes in sequencing and array-based technologies; and Integrated DNA Technologies, providing custom nucleic acids for various applications. Other notable companies include Agilent Technologies, which provides analytical instruments and services to the life sciences industry; and Eurofins Genomics, a leader in genomic services. Show Less Read more